2023-05-17-艾昆纬-利用人工智能建模改进患者识别95x（英）_15页_2mb

Summary of "Opportunities in Moving Care Nearer the Patient" White Paper by IQVIA

Introduction

The white paper explores the shift toward near-to-patient care, emphasizing patient-centricity and personalized medicine to improve healthcare flexibility. It highlights structural changes that move care outside traditional hospital settings, accelerated by the COVID-19 pandemic, focusing on treating patients at various endpoints for better outcomes.

Key Elements of Near-to-Patient Care

• Points of Administration: Includes at-home treatment (with or without HCP assistance), outpatient clinics, mobile clinics, and local pharmacies, offering diverse care locations.
• Telehealth Solutions: Covers teleconsultations, telediagnosis, and digital therapeutics (DTx), such as Germany's DiGA prescriptions growing steadily, reducing in-person visits and enhancing remote monitoring.
• Formulations and Devices: Features patient-friendly devices like autoinjectors and prefilled syringes, with a rise in subcutaneous and oral formulations. Devices with hidden needles and digital tools like smartwatches collect health data for better chronic disease management.

Implementation Challenges

• Regulatory: Lack of harmonized policies and legal barriers, e.g., Italy's absence of home drug delivery frameworks.
• Financial: Insufficient incentives and frameworks, hindering investment in near-to-patient systems despite potential cost savings.
• Behavioural: Resistance from healthcare professionals (HCPs) due to unfamiliarity with new technologies, and patient hesitancy (e.g., preference for face-to-face care or lack of technical literacy).
• Logistical: Complexities in transporting and storing medicines, especially high-value items, with risks of counterfeit drugs and increased last-mile delivery needs, straining infrastructure.

Opportunities for Stakeholders

• Patients: Increased flexibility in time and location, choice in care mode, and better compliance leading to improved outcomes.
• Healthcare Systems: Cost reductions through fewer hospital admissions, greater efficiency, and fulfillment of medicine access targets.
• Pharma Companies: Expanded market access to a larger patient base, development of easier-to-administer formulations, and new revenue streams via DTx and partnerships.
• Distributors: Growth into service provision, home delivery reimbursements, and investment in logistics like cold chain management.
• Pharmacies: Shift to administration roles, new revenue from expanded services, and integration of automation to handle increased prescription volumes.

Conclusion

Near-to-patient care offers significant benefits, including enhanced patient convenience, cost savings, and innovation, but requires overcoming regulatory, financial, behavioural, and logistical hurdles for widespread adoption. Stakeholder collaboration and clear policies are key to realizing these opportunities.